These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 23594483

  • 1. 4-Methylumbelliferone inhibits the phosphorylation of hyaluronan synthase 2 induced by 12-O-tetradecanoyl-phorbol-13-acetate.
    Kuroda Y, Kasai K, Nanashima N, Nozaka H, Nakano M, Chiba M, Yoneda M, Nakamura T.
    Biomed Res; 2013 Apr; 34(2):97-103. PubMed ID: 23594483
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone.
    Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, Maruo Y, Sato H, Yasuda T, Mita S, Kimata K, Itano N.
    J Biol Chem; 2004 Aug 06; 279(32):33281-9. PubMed ID: 15190064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stimulation of small proteoglycan synthesis by the hyaluronan synthesis inhibitor 4-methylumbelliferone in human skin fibroblasts.
    Funahashi M, Nakamura T, Kakizaki I, Mizunuma H, Endo M.
    Connect Tissue Res; 2009 Aug 06; 50(3):194-202. PubMed ID: 19444760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors.
    Edward M, Quinn JA, Pasonen-Seppänen SM, McCann BA, Tammi RH.
    Br J Dermatol; 2010 Jun 06; 162(6):1224-32. PubMed ID: 20163414
    [Abstract] [Full Text] [Related]

  • 11. Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling.
    Pasonen-Seppänen S, Takabe P, Edward M, Rauhala L, Rilla K, Tammi M, Tammi R.
    Histochem Cell Biol; 2012 Dec 06; 138(6):895-911. PubMed ID: 22825838
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K, Yokouchi M, Murayama T, Minami S, Komiya S.
    Int J Oncol; 2006 Jul 06; 29(1):175-83. PubMed ID: 16773198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 17. Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).
    Morohashi H, Kon A, Nakai M, Yamaguchi M, Kakizaki I, Yoshihara S, Sasaki M, Takagaki K.
    Biochem Biophys Res Commun; 2006 Jul 14; 345(4):1454-9. PubMed ID: 16730656
    [Abstract] [Full Text] [Related]

  • 18. Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.
    Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall VC, Tammi M, De Luca G, Passi A.
    J Biol Chem; 2012 Oct 12; 287(42):35544-35555. PubMed ID: 22887999
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.